Clinical Trial: Anti-Obesity and Bowel Movement Improvement Effects of Food Component Intake: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study (Japan)

Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062514) titled 'Anti-Obesity and Bowel Movement Improvement Effects of Food Component Intake: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study' on Aug. 7.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - KSO Corporation

Condition: Condition - Healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to evaluate the anti-obesity and bowel movement improvement effects of a food component ...